Where I see patients (1)

"A lot of mothers will undergo any procedure to save the life of their child. It's up to us to make sure what we're offering them has the potential for true benefit and a minimal risk of harm."
Selected research
-
Thymic and extrathymic Aire-expressing cells in maternal-fetal tolerance.
Immunological reviews
-
Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients.
Orphanet journal of rare diseases
-
Consensus statement for the perinatal management of patients with α thalassemia major.
Blood advances
Clinical trials
International Registry of Patients With Alpha Thalassemia
Number of fetuses diagnosed with alpha thalassemia who survive to birth, compared to number of fetuses diagnosed with alpha thalassemia who have fetal demise or are terminated in utero. This is measured in number of fetuses alive ...
Recruiting
In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseases
Adverse and serious adverse events including, but not limited to, death within 24 hours after the procedure, stillbirth, death prior to initial hospital discharge,increased response with antibody development above that expected wi...
Recruiting
My work
Contact me
- Request appointment
- Refer a patient
- (800) 793-3887